Auto - Parts
Compare Stocks
4 / 10Stock Comparison
THRM vs ADNT vs LEA vs VC
Revenue, margins, valuation, and 5-year total return — side by side.
Auto - Parts
Auto - Parts
Auto - Parts
THRM vs ADNT vs LEA vs VC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Auto - Parts | Auto - Parts | Auto - Parts | Auto - Parts |
| Market Cap | $944M | $1.71B | $6.85B | $3.01B |
| Revenue (TTM) | $1.53B | $14.94B | $23.52B | $3.79B |
| Net Income (TTM) | $23M | $59M | $528M | $201M |
| Gross Margin | 23.6% | 6.4% | 5.3% | 13.4% |
| Operating Margin | 4.7% | 3.0% | 3.2% | 7.9% |
| Forward P/E | 11.6x | 10.5x | 9.4x | 13.1x |
| Total Debt | $295M | $2.40B | $4.10B | $540M |
| Cash & Equiv. | $161M | $958M | $1.03B | $771M |
THRM vs ADNT vs LEA vs VC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Gentherm Incorporat… (THRM) | 100 | 75.7 | -24.3% |
| Adient plc (ADNT) | 100 | 128.6 | +28.6% |
| Lear Corporation (LEA) | 100 | 127.6 | +27.6% |
| Visteon Corporation (VC) | 100 | 156.0 | +56.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: THRM vs ADNT vs LEA vs VC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
THRM is the clearest fit if your priority is growth exposure.
- Rev growth 2.6%, EPS growth -70.9%, 3Y rev CAGR 7.5%
- 2.6% revenue growth vs VC's -2.5%
ADNT is the clearest fit if your priority is momentum.
- +73.9% vs THRM's +19.1%
LEA carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 0 yrs, beta 1.14, yield 2.3%
- Beta 1.14, yield 2.3%, current ratio 1.35x
- Lower P/E (9.4x vs 13.1x)
- Beta 1.14 vs ADNT's 1.43, lower leverage
VC is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 52.8% 10Y total return vs LEA's 38.9%
- Lower volatility, beta 1.14, Low D/E 32.7%, current ratio 1.80x
- 5.3% margin vs ADNT's 0.4%
- 6.1% ROA vs ADNT's 0.7%, ROIC 19.5% vs 8.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.6% revenue growth vs VC's -2.5% | |
| Value | Lower P/E (9.4x vs 13.1x) | |
| Quality / Margins | 5.3% margin vs ADNT's 0.4% | |
| Stability / Safety | Beta 1.14 vs ADNT's 1.43, lower leverage | |
| Dividends | 2.3% yield, vs VC's 0.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +73.9% vs THRM's +19.1% | |
| Efficiency (ROA) | 6.1% ROA vs ADNT's 0.7%, ROIC 19.5% vs 8.7% |
THRM vs ADNT vs LEA vs VC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
THRM vs ADNT vs LEA vs VC — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
VC leads in 3 of 6 categories
ADNT leads 1 • LEA leads 1 • THRM leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
VC leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
LEA is the larger business by revenue, generating $23.5B annually — 15.3x THRM's $1.5B. Profitability is closely matched — net margins range from 5.3% (VC) to 0.4% (ADNT). On growth, THRM holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1.5B | $14.9B | $23.5B | $3.8B |
| EBITDAEarnings before interest/tax | $127M | $688M | $1.2B | $382M |
| Net IncomeAfter-tax profit | $23M | $59M | $528M | $201M |
| Free Cash FlowCash after capex | $79M | $272M | $732M | $305M |
| Gross MarginGross profit ÷ Revenue | +23.6% | +6.4% | +5.3% | +13.4% |
| Operating MarginEBIT ÷ Revenue | +4.7% | +3.0% | +3.2% | +7.9% |
| Net MarginNet income ÷ Revenue | +1.5% | +0.4% | +2.2% | +5.3% |
| FCF MarginFCF ÷ Revenue | +5.1% | +1.8% | +3.1% | +8.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +11.3% | +7.0% | +4.7% | +2.1% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +108.5% | +124.2% | -0.4% |
Valuation Metrics
ADNT leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 15.4x trailing earnings, VC trades at a 70% valuation discount to THRM's 51.4x P/E. On an enterprise value basis, ADNT's 4.1x EV/EBITDA is more attractive than THRM's 8.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $944M | $1.7B | $6.8B | $3.0B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $3.2B | $9.9B | $2.8B |
| Trailing P/EPrice ÷ TTM EPS | 51.35x | -6.45x | 16.60x | 15.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 11.57x | 10.50x | 9.39x | 13.12x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.65x | — |
| EV / EBITDAEnterprise value multiple | 8.21x | 4.13x | 6.10x | 6.34x |
| Price / SalesMarket cap ÷ Revenue | 0.63x | 0.12x | 0.29x | 0.80x |
| Price / BookPrice ÷ Book value/share | 1.32x | 0.84x | 1.39x | 1.88x |
| Price / FCFMarket cap ÷ FCF | 15.45x | 8.40x | 12.99x | 10.88x |
Profitability & Efficiency
VC leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
VC delivers a 12.7% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $3 for ADNT. VC carries lower financial leverage with a 0.33x debt-to-equity ratio, signaling a more conservative balance sheet compared to ADNT's 1.11x. On the Piotroski fundamental quality scale (0–9), LEA scores 7/9 vs THRM's 5/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.2% | +2.8% | +11.1% | +12.7% |
| ROA (TTM)Return on assets | +1.6% | +0.7% | +4.0% | +6.1% |
| ROICReturn on invested capital | +7.3% | +8.7% | +9.7% | +19.5% |
| ROCEReturn on capital employed | +8.2% | +8.0% | +11.5% | +15.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.41x | 1.11x | 0.79x | 0.33x |
| Net DebtTotal debt minus cash | $134M | $1.4B | $3.1B | -$231M |
| Cash & Equiv.Liquid assets | $161M | $958M | $1.0B | $771M |
| Total DebtShort + long-term debt | $295M | $2.4B | $4.1B | $540M |
| Interest CoverageEBIT ÷ Interest expense | 5.83x | 2.02x | 7.55x | 124.00x |
Total Returns (Dividends Reinvested)
VC leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in VC five years ago would be worth $8,912 today (with dividends reinvested), compared to $4,200 for THRM. Over the past 12 months, ADNT leads with a +73.9% total return vs THRM's +19.1%. The 3-year compound annual growth rate (CAGR) favors LEA at 4.3% vs THRM's -19.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -16.3% | +14.9% | +14.7% | +16.4% |
| 1-Year ReturnPast 12 months | +19.1% | +73.9% | +61.3% | +40.3% |
| 3-Year ReturnCumulative with dividends | -48.0% | -39.0% | +13.4% | -17.2% |
| 5-Year ReturnCumulative with dividends | -58.0% | -55.6% | -23.2% | -10.9% |
| 10-Year ReturnCumulative with dividends | -14.9% | -51.8% | +38.9% | +52.8% |
| CAGR (3Y)Annualised 3-year return | -19.6% | -15.2% | +4.3% | -6.1% |
Risk & Volatility
LEA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
LEA is the less volatile stock with a 1.14 beta — it tends to amplify market swings less than ADNT's 1.43 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LEA currently trades 94.7% from its 52-week high vs THRM's 78.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.43x | 1.43x | 1.14x | 1.14x |
| 52-Week HighHighest price in past year | $39.48 | $27.32 | $142.84 | $129.10 |
| 52-Week LowLowest price in past year | $25.47 | $11.89 | $85.04 | $80.08 |
| % of 52W HighCurrent price vs 52-week peak | +78.0% | +80.1% | +94.7% | +87.0% |
| RSI (14)Momentum oscillator 0–100 | 59.7 | 58.6 | 67.4 | 67.6 |
| Avg Volume (50D)Average daily shares traded | 239K | 838K | 558K | 601K |
Analyst Outlook
Evenly matched — LEA and VC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: THRM as "Buy", ADNT as "Hold", LEA as "Hold", VC as "Buy". Consensus price targets imply 22.5% upside for ADNT (target: $27) vs -6.4% for LEA (target: $127). For income investors, LEA offers the higher dividend yield at 2.27% vs VC's 0.48%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy |
| Price TargetConsensus 12-month target | $36.67 | $26.80 | $126.57 | $121.00 |
| # AnalystsCovering analysts | 15 | 27 | 31 | 23 |
| Dividend YieldAnnual dividend ÷ price | — | — | +2.3% | +0.5% |
| Dividend StreakConsecutive years of raises | 0 | 1 | 0 | 2 |
| Dividend / ShareAnnual DPS | — | — | $3.08 | $0.54 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.1% | +7.3% | +4.7% | +1.9% |
VC leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ADNT leads in 1 (Valuation Metrics). 1 tied.
THRM vs ADNT vs LEA vs VC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is THRM or ADNT or LEA or VC a better buy right now?
For growth investors, Gentherm Incorporated (THRM) is the stronger pick with 2.
6% revenue growth year-over-year, versus -2. 5% for Visteon Corporation (VC). Visteon Corporation (VC) offers the better valuation at 15. 4x trailing P/E (13. 1x forward), making it the more compelling value choice. Analysts rate Gentherm Incorporated (THRM) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — THRM or ADNT or LEA or VC?
On trailing P/E, Visteon Corporation (VC) is the cheapest at 15.
4x versus Gentherm Incorporated at 51. 4x. On forward P/E, Lear Corporation is actually cheaper at 9. 4x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — THRM or ADNT or LEA or VC?
Over the past 5 years, Visteon Corporation (VC) delivered a total return of -10.
9%, compared to -58. 0% for Gentherm Incorporated (THRM). Over 10 years, the gap is even starker: VC returned +52. 8% versus ADNT's -51. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — THRM or ADNT or LEA or VC?
By beta (market sensitivity over 5 years), Lear Corporation (LEA) is the lower-risk stock at 1.
14β versus Adient plc's 1. 43β — meaning ADNT is approximately 26% more volatile than LEA relative to the S&P 500. On balance sheet safety, Visteon Corporation (VC) carries a lower debt/equity ratio of 33% versus 111% for Adient plc — giving it more financial flexibility in a downturn.
05Which is growing faster — THRM or ADNT or LEA or VC?
By revenue growth (latest reported year), Gentherm Incorporated (THRM) is pulling ahead at 2.
6% versus -2. 5% for Visteon Corporation (VC). On earnings-per-share growth, the picture is similar: Lear Corporation grew EPS -9. 1% year-over-year, compared to -1795. 0% for Adient plc. Over a 3-year CAGR, THRM leads at 7. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — THRM or ADNT or LEA or VC?
Visteon Corporation (VC) is the more profitable company, earning 5.
3% net margin versus -1. 9% for Adient plc — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VC leads at 8. 8% versus 3. 0% for ADNT. At the gross margin level — before operating expenses — THRM leads at 23. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is THRM or ADNT or LEA or VC more undervalued right now?
On forward earnings alone, Lear Corporation (LEA) trades at 9.
4x forward P/E versus 13. 1x for Visteon Corporation — 3. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ADNT: 22. 5% to $26. 80.
08Which pays a better dividend — THRM or ADNT or LEA or VC?
In this comparison, LEA (2.
3% yield), VC (0. 5% yield) pay a dividend. THRM, ADNT do not pay a meaningful dividend and should not be held primarily for income.
09Is THRM or ADNT or LEA or VC better for a retirement portfolio?
For long-horizon retirement investors, Lear Corporation (LEA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
14), 2. 3% yield). Both have compounded well over 10 years (LEA: +38. 9%, ADNT: -51. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between THRM and ADNT and LEA and VC?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: THRM is a small-cap quality compounder stock; ADNT is a small-cap quality compounder stock; LEA is a small-cap deep-value stock; VC is a small-cap deep-value stock. LEA pays a dividend while THRM, ADNT, VC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.